James Christopher Barry - Mar 28, 2022 Form 4 Insider Report for NUVASIVE INC (NUVA)

Role
Chief Executive Officer, Director
Signature
/s/ Nathaniel B. Sisitsky, Attorney-in-fact for James Christopher Barry
Stock symbol
NUVA
Transactions as of
Mar 28, 2022
Transactions value $
-$275,000
Form type
4
Date filed
3/30/2022, 05:50 PM
Previous filing
Mar 3, 2022
Next filing
Apr 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVA Common Stock Sale -$275K -5K -8.3% $55.00 55.2K Mar 28, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1.
F2 Shares directly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards.